Zura Bio Limited EBIT

Zura Bio Limited (94E.F) currently reports a EBIT of $-92M as of June 2026. That compares with $-72M in the prior-year period — down 27.5% year over year. That is below the sector sector average of $-25M. Use the charts on this page to explore Zura Bio Limited's EBIT history and peer comparisons.

Zura Bio Limited's EBIT decreased from $-72M to $-92M — a 27.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zura Bio Limited's EBIT of $-92M is lower than the its sector sector average of $-25M. That is roughly 264.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Zura Bio Limited reported $-92M in EBIT as of June 2026. That compares with $-72M in the prior-year period — down 27.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-92M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-25M. From there, open related valuation or income-statement pages for Zura Bio Limited, and consider following 94E.F for alerts when major investors trade the stock.